Takara Bio, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3460200003
JPY
1,147.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sumitomo Bakelite Co., Ltd.
JEOL Ltd.
Shimadzu Corp.
Asahi Intecc Co., Ltd.
Sysmex Corp.
Fukuda Denshi Co., Ltd.
Nakanishi, Inc.
Mani, Inc.
Nihon Kohden Corp.
PHC Holdings Corp.
Takara Bio, Inc.

Why is Takara Bio, Inc. ?

1
With a fall in Net Sales of -12.89%, the company declared Very Negative results in Dec 25
  • OPERATING CASH FLOW(Y) Lowest at JPY 4,226 MM
  • NET SALES(Q) At JPY 9,598 MM has Fallen at -12.89%
  • ROCE(HY) Lowest at -6.86%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 35.58%, its profits have fallen by -14.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Takara Bio, Inc. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Takara Bio, Inc.
35.58%
0.37
37.00%
Japan Nikkei 225
36.73%
1.30
28.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.44%
EBIT Growth (5y)
-18.45%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.44
Tax Ratio
45.57%
Dividend Payout Ratio
196.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.86%
ROE (avg)
10.18%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
66
Industry P/E
Price to Book Value
0.82
EV to EBIT
28.90
EV to EBITDA
9.70
EV to Capital Employed
0.76
EV to Sales
1.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.63%
ROE (Latest)
1.23%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 5.49 times

-39What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at JPY 4,226 MM

NET SALES(Q)

At JPY 9,598 MM has Fallen at -12.89%

ROCE(HY)

Lowest at -6.86%

RAW MATERIAL COST(Y)

Grown by 9.82% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -9.73 %

INTEREST(Q)

Highest at JPY 177 MM

OPERATING PROFIT(Q)

Lowest at JPY -1,201 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -12.51 %

PRE-TAX PROFIT(Q)

Lowest at JPY -2,654 MM

NET PROFIT(Q)

Lowest at JPY -2,707 MM

Here's what is working for Takara Bio, Inc.

Debtors Turnover Ratio
Highest at 5.49 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Takara Bio, Inc.

Net Sales
At JPY 9,598 MM has Fallen at -12.89%
over average net sales of the previous four periods of JPY 11,018.75 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (JPY MM)

Pre-Tax Profit
At JPY -2,654 MM has Fallen at -1,788.97%
over average net sales of the previous four periods of JPY -140.5 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit
At JPY -2,707 MM has Fallen at -373.1%
over average net sales of the previous four periods of JPY -572.19 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Operating Cash Flow
Lowest at JPY 4,226 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (JPY MM)

Interest
At JPY 177 MM has Grown at 40.48%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest
Highest at JPY 177 MM
in the last five periods and Increased by 40.48% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Operating Profit
Lowest at JPY -1,201 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin
Lowest at -12.51 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at JPY -2,654 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit
Lowest at JPY -2,707 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Debt-Equity Ratio
Highest at -9.73 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 9.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales